Call Us Sign-Up/Sign-In
Spain Brazil Russia France Germany China Korea Japan

Artificial Intelligence driven Marketing Communications

Generic Drugs Market 2021 Company Profiles, Size, Share and Market Intelligence Forecast To 2026

iCrowdNewswire   Feb 22, 2021  5:00 AM ET

Generic Drugs Industry


Wiseguyreports.Com Adds “Generic Drugs -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024” To Its Research Database

The global market for generic drugs should reach $533 billion by 2021 from $352 billion in 2016 at a compound annual growth rate (CAGR) of 8.7%, from 2016 to 2021

This report discusses the implications of all the above-mentioned trends, in the context of the current size and growth of the generics market, both in global terms and analyzed by the most important national markets. The nature and structure of the generics industry is discussed, with profiles of the leading 20+ generics companies and an update on M&A activity. Five-year sales forecasts are provided for the national markets and the major therapeutic categories of products involved.

Request for Sample Report @

Report Includes:

– An overview of the global markets for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs (e.g., hypolipidaemics and antihypertensives), and drugs for respiratory conditions, including asthma and COPD 
– Analyses of global market trends, with data from 2015, estimates for 2016, and projections of compound annual growth rates (CAGRs) through 2021 
– Examination of strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by “originator” companies to forestall generic competition 
– Discussion of important trends by product categories and major country markets, acknowledging that Brazil, China, India, Mexico, and Russia are among the rising markets for generic activity 
– Profiles of major players and leading generics companies 
– A look at recent merger and acquisition activity

Actavis (Teva) 
Aspen Pharmacare Holdings Ltd. 
Aurobindo Pharma Ltd. 
Cipla Ltd. 
Dr. Reddy’s Laboratories Ltd. 
Egis Pharmaceuticals Plc 
Fresenius Kabi 
Hospira Inc. 
Lupin, Ltd. 
Mylan Inc. 
Par Pharmaceutical, Inc. 
Sandoz International Gmbh 
Stada Arzneimittel 
Strides Shasun Ltd. 
Sun Pharmaceutical Industries Ltd. 
Teva Pharmaceutical Industries Ltd. 
Wockhardt Ltd. 
Zydus Cadila

Leave a Query @


Read Other Reports from our Database :

About the Author :

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Contact Information:

Wiseguy Research Consultants

Keywords:    Generic Drugs, Generic Drugs Industry, Generic Drugs Market, Generic Drugs Price, Generic Drugs Market Size, Generic Drugs Market Share, Generic Drugs Market Trend, Generic Drugs Market Analysis, Generic Drugs Market Forecast, Generic Drugs Consumption Market, Generic Drugs Sales Market, Generic Drugs Segmentation, Generic Drugs Manufacturers, Generic Drugs Prospectus, Generic Drugs Industry Trends, Generic Drugs Market Share, Generic Drugs Market Growth, Generic Drugs Market Trends, Generic Drugs Market Size, Global Generic Drugs Industry, Global Generic Drugs Market Trends, Generic Drugs Growth, Global Generic Drugs Market Share, Global Generic Drugs Size, Generic Drugs Market Analysis, Generic Drugs Market Growth

Tags:    iCN Internal Distribution, Research Newswire, English